rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1-2
|
pubmed:dateCreated |
2001-10-11
|
pubmed:abstractText |
Rhesus macaques immunized with the HIV-1 SF162DeltaV2 gp140 envelope using the DNA-prime plus protein-boost vaccination methodology, developed HIV envelope-specific T-cell lymphoproliferative responses and potent neutralizing antibodies. To evaluate the protective potential of these antibodies during acute infection, the animals were depleted of their CD8+ T lymphocytes using specific monoclonal antibodies and subsequently challenged intravenously with the pathogenic SHIV(SF162P4) isolate. As compared to non-vaccinated animals (one of which died from AIDS 16 weeks post-exposure) the vaccinated macaques had lower levels of peak viremia, rapidly cleared virus from the periphery and developed delayed seroconversion to SIV core antigens.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/AIDS Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Gene Products, env,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/SAIDS Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Vaccines, DNA,
http://linkedlifedata.com/resource/pubmed/chemical/env Gene Products, Human...,
http://linkedlifedata.com/resource/pubmed/chemical/gp140 envelope protein, Human...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0165-2478
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
79
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
47-55
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11595289-AIDS Vaccines,
pubmed-meshheading:11595289-Animals,
pubmed-meshheading:11595289-CD8-Positive T-Lymphocytes,
pubmed-meshheading:11595289-Gene Products, env,
pubmed-meshheading:11595289-HIV Antibodies,
pubmed-meshheading:11595289-HIV-1,
pubmed-meshheading:11595289-Lymphocyte Activation,
pubmed-meshheading:11595289-Lymphocyte Depletion,
pubmed-meshheading:11595289-Macaca mulatta,
pubmed-meshheading:11595289-Neutralization Tests,
pubmed-meshheading:11595289-SAIDS Vaccines,
pubmed-meshheading:11595289-Sequence Deletion,
pubmed-meshheading:11595289-Simian immunodeficiency virus,
pubmed-meshheading:11595289-T-Lymphocytes,
pubmed-meshheading:11595289-Vaccines, DNA,
pubmed-meshheading:11595289-env Gene Products, Human Immunodeficiency Virus
|
pubmed:year |
2001
|
pubmed:articleTitle |
DNA-immunization with a V2 deleted HIV-1 envelope elicits protective antibodies in macaques.
|
pubmed:affiliation |
Aaron Diamond AIDS Research Center, The Rockefeller University, New York, NY 10021-6399, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|